Currently holds a position at Cymabay Therapeutics Inc
Position | Company | Period |
---|---|---|
Vice President - Finance, Principal Financial Officer, Principal Accounting Officer | Cymabay Therapeutics Inc | April 27, 2017 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-01-16 | 2024-01-16 |
Cymabay Therapeutics Inc
(CBAY)
|
PS Planned sale |
10,000
-100.0%
23.58235,806 USD |
10,000 -100.0% | 23.58 | 235,806 USD | |
2023-12-15 | 2023-12-15 |
Cymabay Therapeutics Inc
(CBAY)
|
PS Planned sale |
11,497
-100.0%
21.99252,799 USD |
11,497 -100.0% | 21.99 | 252,799 USD | |
2023-12-15 | 2023-12-15 |
Cymabay Therapeutics Inc
(CBAY)
|
PS Planned sale |
10,000
-100.0%
21.98219,847 USD |
10,000 -100.0% | 21.98 | 219,847 USD | |
2023-10-18 | 2023-10-16 |
Cymabay Therapeutics Inc
(CBAY)
|
PS Planned sale |
0
13.760 USD |
0 | 13.76 | 0 USD | |
2023-09-19 | 2023-09-15 |
Cymabay Therapeutics Inc
(CBAY)
|
PS Planned sale |
0
16.870 USD |
0 | 16.87 | 0 USD | |
2023-09-19 | 2023-09-15 |
Cymabay Therapeutics Inc
(CBAY)
|
PS Planned sale |
0
16.870 USD |
0 | 16.87 | 0 USD | |
2023-08-16 | 2023-08-15 |
Cymabay Therapeutics Inc
(CBAY)
|
PS Planned sale |
0
12.130 USD |
0 | 12.13 | 0 USD | |
2023-08-16 | 2023-08-15 |
Cymabay Therapeutics Inc
(CBAY)
|
PS Planned sale |
0
11.920 USD |
0 | 11.92 | 0 USD | |
2023-08-11 | 2023-08-09 |
Cymabay Therapeutics Inc
(CBAY)
|
PS Planned sale |
20,945
-100.0%
12.35258,744 USD |
20,945 -100.0% | 12.35 | 258,744 USD |